Prevention and Treatment of Virulent Bacterial Biofilms with an Enzymatic Nitric Oxide-Releasing Dressing
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The use of percutaneous medical devices often results in nosocomial infections. Attachment of microorganisms to the surfaces of these medical devices triggers biofilm formation, which presents significant complications to the health of a patient and may lead to septicemia, thromboembolism, or endocarditis if not correctly treated. Although several antimicrobials are commonly used for prevention of biofilm formation, they have limited efficacy against formed biofilms. In this study, we report the use of an enzymatic, gaseous nitric oxide (gNO)-releasing dressing for the prevention and treatment of Acinetobacter baumannii , methicillin-resistant Staphylococcus aureus , and Pseudomonas aeruginosa biofilms. Results show that the bactericidal activity against biofilms of the test strains was dependent on time and rate of gNO release from the dressing. Following 6 h of treatment, gNO-releasing dressings significantly inhibited the growth of test strains relative to vehicle control dressings, demonstrating eradication of bacterial concentrations of up to 10 5 CFU/cm 2 . Complete cell death was observed for both prevention of biofilm formation and treatment of 24-h-grown biofilms after 6 h of treatment with the gNO-releasing dressings. Further, gNO-releasing dressings were more efficient against formed biofilms than other antimicrobial agents currently used. These results demonstrate that the gNO-releasing dressing can produce sufficient levels of gNO over a therapeutically relevant duration for maximal bactericidal effects against virulent bacterial strains known to cause nosocomial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
Edwards, R., & Harding, K. G. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200404000-00004 · Cited by 1,099 · cited 1×
“Moreover, through the continuous release of bacterial toxins and innate proinflammatory molecules, there is increased ancillary tissue damage that results in further biofilm formation in adjacent tissues (13).”
BackgroundNitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
Barraud, N., Storey, M. V., Moore, Z. P., Webb, J. S., Rice, S. A., & Kjelleberg, S. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2009.00098.x · Cited by 289 · cited 1×
“Though an array of therapies has been tested for the prevention of biofilm formation, evidence of antimicrobial activity of NO for treatment of biofilms does not yet exist (4, 5, 14, 24, 26, 40, 42).”
BackgroundPotential application of gaseous nitric oxide as a topical antimicrobial agent
Ghaffari, A., Miller, C. C., McMullin, B., & Ghahary, A. (2006) · Nitric Oxide · doi:10.1016/j.niox.2005.08.003 · Cited by 236 · cited 4×
“The gNO release rates correspond to releasing concentrations of above 200 ppmv, which was previously reported to have bactericidal activity against planktonic bacteria (18) (Fig.”
BackgroundInfluentialGorwitz, R. J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815819bb · Cited by 164 · cited 1×
“Pseudomonas aeruginosa and multidrug-resistant organisms (MDROs) such as Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus (MRSA) represent a serious problem in hospitals due to nosocomial transmission and the difficulty in treating these infections with contemporary therapies (1, 19, 35).”
BackgroundAcceleration of nitric oxide autoxidation and nitrosation by membranes
Möller, M. N., Li, Q., Lancaster, J. R., & Denicola, A. (2007) · IUBMB Life · doi:10.1080/15216540701311147 · Cited by 122
Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation
Privett, B. J., Nutz, S. T., & Schoenfisch, M. H. (2010) · Biofouling · doi:10.1080/08927014.2010.534552 · Cited by 45 · cited 1×
“Though an array of therapies has been tested for the prevention of biofilm formation, evidence of antimicrobial activity of NO for treatment of biofilms does not yet exist (4, 5, 14, 24, 26, 40, 42).”
Background
Cited by
Combating medical device fouling
Harding, J. L., & Reynolds, M. M. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.12.004 · Cited by 261
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Barraud, N., Kelso, M., Rice, S., & Kjelleberg, S. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140905112822 · Cited by 255
Nitric oxide regulation of bacterial biofilms
Arora, D. P., Hossain, S., Xu, Y., & Boon, E. M. (2015) · Biochemistry · doi:10.1021/bi501476n · Cited by 206
Harding, J. L., Metz, J. M., & Reynolds, M. M. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201402529 · Cited by 67
Metadata
- Authors
- Sulemankhil, I., Ganopolsky, J. G., Dieni, C. A., Dan, A. F., Jones, M. L., & Prakash, S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-12
- Volume
- 56
- Issue
- 12
- Pages
- 6095-6103
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2112649458
- Cited by
- 55
- References
- 8
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention and Treatment of Virulent Bacterial Biofilms with an Enzymatic Nitric Oxide-Releasing Dressing. https://app.cochat.ai/papers/10.1128/aac.01173-12
- The paper
- Sulemankhil, I., Ganopolsky, J. G., Dieni, C. A., Dan, A. F., Jones, M. L., & Prakash, S. (2012). Prevention and Treatment of Virulent Bacterial Biofilms with an Enzymatic Nitric Oxide-Releasing Dressing. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01173-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.